Key result
Captopril and losartan increase inflammatory cell infiltration without altering angiogenesis or fibroblast proliferation.
Why the study?
Does captopril or losartan affect inflammatory response, angiogenesis, and fibroblast activity during early wound healing in hypertensive rats?
Does captopril or losartan affect inflammatory response, angiogenesis, and fibroblast activity during early wound healing in hypertensive rats?
Answers are grounded in this paper and cite their sources.
In a hypertensive rat model, captopril and losartan increased inflammatory cell infiltration during early wound healing without affecting angiogenesis or fibroblast proliferation.
PURPOSE: To compare the effects of captopril and losartan on inflammatory response, angiogenesis, and fibroblast activity during the early phase of wound healing in hypertensive rats. METHODS: Twenty-seven paraffin-embedded skin wound samples from hypertensive rats were analyzed: control group (n = 8), losartan-treated group (n = 9), and captopril-treated group (n = 10). Histological and immunohistochemical analyses were performed on postoperative day 4. Hematoxylin-eosin staining was used to evaluate general wound structure, and immunohistochemistry with anti-leukocyte common antigen, anti-CD34, and anti-smooth muscle actin was performed to assess inflammatory cells, angiogenesis, and fibroblast activity, respectively. RESULTS: No significant differences were observed in angiogenesis (p > 0.05) or fibroblast number (p > 0.05) between groups. However, the inflammatory reaction was significantly higher in captopril-treated (p = 0.0459) and losartan-treated (p = 0.0452) groups compared with the control group, with no significant difference between the two treated groups. CONCLUSION: Neither captopril nor losartan influenced angiogenesis or fibroblast proliferation in the early healing phase. However, both drugs increased inflammatory cell infiltration.
No takes yet. Share an insight, caveat, or question.
Braz et al. (2026) studied Hypertensive rats with skin wounds (n=27). Captopril and losartan vs. Control group was evaluated on Inflammatory response, angiogenesis, and fibroblast activity (p=0.0459). Captopril and losartan increased inflammatory cell infiltration compared to control but did not influence angiogenesis or fibroblast proliferation.
Synapse has enriched 10 related papers. Consider them for comparative context: